Seeking to widen access to hepatitis C treatments around the world, the Medicines Patent Pool and AbbVie (ABBV) signed a voluntary licensing deal in which the drug maker will allow a generic version of one of its medicines to be made and sold in dozens of countries. Yet the agreement is also being criticized for limiting availability compared with similar licensing arrangements that other companies have reached.
Specifically, AbbVie has agreed to provide its Mavyret hepatitis C pill to 99 low- and middle-income countries and territories through royalty-free arrangements with generic drug manufacturers. The arrangements will be facilitated by MPP, which is a nonprofit backed by the United Nations that works with drug makers to widen access to medicines.
About the Author Reprints
I had Hep-c 1 for something like 20 years before it was found in my bloodstream. My hepatologist proceeded to take a blood test and bingo, she caught my Hep after all those years. A biopsy also determined that I had compensated cirrhosis, which the Dr. explained to me that was the very begging stages of cirrhosis, advise to take Sovaldi. However, it was so expensive, thankfully I heard generic Indian sovaldi, In Jan 2017 I started the 12-weeks Indian generic sovaldi treatment course bought from medixocentre.com , “I’ve read a lot of forums about the Sovaldi treatment because I was very worried the first time I had any treatment at all. In 4 weeks I was undetectable and at my request I was tested last month 18 months still undetectable! No side effects!” I’m very grateful!” And My friend recently started treatment & after 4 weeks virus is gone, however, the doctor said to complete course of 12-weeks. I hope it would be the same for everyone. We’re hoping if you can release the cheaper generic as soon as possible for this viral disease. There are dozens of poor people in several countries who can’t afford this costly treatment, who really needs this.